| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/12/2001 | CA2396529A1 O-superfamily conotoxin peptides |
| 07/12/2001 | CA2396315A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them |
| 07/12/2001 | CA2396257A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | CA2396239A1 Novel immune enhancing compositions |
| 07/12/2001 | CA2396234A1 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 07/12/2001 | CA2396149A1 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | CA2396059A1 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | CA2395984A1 Novel heteroaryl derivatives, their preparation and use |
| 07/12/2001 | CA2395955A1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension |
| 07/12/2001 | CA2395892A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | CA2395887A1 Methods for pulmonary delivery of interleukin-2 |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395795A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 07/12/2001 | CA2395742A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | CA2395660A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | CA2395636A1 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | CA2395625A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | CA2395606A1 Novel indole derivatives |
| 07/12/2001 | CA2395487A1 Composition for the treatment of damaged tissue |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2394721A1 Product for treating gynecomastia |
| 07/12/2001 | CA2394297A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | CA2331059A1 Method of reducing morbidity and the risk of mortality |
| 07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
| 07/11/2001 | EP1114822A2 Indoles and tetrahydroisoquinolines containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/11/2001 | EP1114817A1 Substituted benzylamino piperidine compounds |
| 07/11/2001 | EP1114183A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/11/2001 | EP1114182A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114151A1 G protein-coupled receptor agonists or antagonists |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114061A1 FACTOR VIIa INHIBITORS |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114052A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114048A1 Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 07/11/2001 | EP1114039A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114037A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 07/11/2001 | EP1114035A1 Quinazoline derivatives and pharmaceutical applications thereof |
| 07/11/2001 | EP1114031A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 07/11/2001 | EP1114028A1 Aza-bicycles which modulate the inhibition of cell adhesion |
| 07/11/2001 | EP1113809A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 07/11/2001 | EP1113802A2 Antiviral combinations of lamivudine and adefovir |
| 07/11/2001 | EP1113801A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION |
| 07/11/2001 | EP1113800A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 07/11/2001 | EP1113796A1 FUSED PYRIDINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 07/11/2001 | EP1113793A1 A new composition |
| 07/11/2001 | EP1113786A1 New pharmaceutical formulation |
| 07/11/2001 | EP1019042A4 Anti-first-pass effect compounds |
| 07/11/2001 | EP0876371B1 Reverse-turn mimetics and methods relating thereto |
| 07/11/2001 | EP0876350B1 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 07/11/2001 | EP0851734B1 Capsules containing freeze-dried powdered green tea leaves |
| 07/11/2001 | EP0823896B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 07/11/2001 | EP0735819B1 Cryptophycins |
| 07/11/2001 | EP0659080B1 Method for the treatment of hair loss |
| 07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
| 07/11/2001 | CN1303429A Therapeutic applications of mature FLINT (mFLINT) polypeptides or OPG3, member of TNF receptor superfamily |
| 07/11/2001 | CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/11/2001 | CN1303389A 3',3'-N-substituted macrolide LHRH antagonists |
| 07/11/2001 | CN1303384A Pyrrolo [1,2-a] pyrazine sPLA2 inhibitor |
| 07/11/2001 | CN1303381A Dipeptidyl peptidase IV effectors |
| 07/11/2001 | CN1303380A Isothizole derivatives useful anticancer agents |
| 07/11/2001 | CN1303376A Compound with activity on muscarinic receptors |
| 07/11/2001 | CN1303372A New heterocyclically substituted amides, their production and their use |
| 07/11/2001 | CN1303368A 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303365A Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 07/11/2001 | CN1303301A Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease |
| 07/11/2001 | CN1303298A Gene therapy approaches to supply apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 07/11/2001 | CN1303290A sPLA Inhibitor ester |
| 07/11/2001 | CN1303288A Combination therapy for treatment of tumors |
| 07/11/2001 | CN1303287A Opioid agonist/antagonist combinations |
| 07/11/2001 | CN1303286A Use of cabergoline in treatment of restless legs syndrome |
| 07/11/2001 | CN1303285A Microemulsion preconcentrates containing piperidine substance P antagonist |
| 07/11/2001 | CN1303284A 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 07/11/2001 | CN1303283A Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
| 07/11/2001 | CN1303282A Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin |
| 07/11/2001 | CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity |
| 07/11/2001 | CN1302663A Substrate tablet containing trimetazidine capable of long time controlled release after oral application |
| 07/11/2001 | CN1302656A Veterinary medicine prepared from sophora seed and its preparing process |
| 07/11/2001 | CN1302628A Hard capsule of superfine notoginseng powder |
| 07/11/2001 | CN1302613A Compound pancreatic ribonucleate for injection |
| 07/11/2001 | CN1302608A Clonidine preparation |
| 07/11/2001 | CN1068327C 2,7-Substituted octahydro-1H-pyrido [1,2-alpha]pyrazin derivatives |
| 07/11/2001 | CN1068324C Crystalline substituted benzothiophene hydrochlorate, pharmaceutical preparation and its use |
| 07/11/2001 | CN1068318C 2-Substituted 1,2,5-thiadiazolidin-3-onel, 1-dioxides and compositions and method of use thereof |
| 07/11/2001 | CN1068308C Substituted benzoylguanide, its preparing process and medicine and application of same |
| 07/11/2001 | CN1068216C 'Shilongqingxue' instant particle for treating hematencephalon |
| 07/10/2001 | US6258953 Arylacrylamide derivatives |
| 07/10/2001 | US6258951 Chemical compounds |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258929 Amino acid sequence of protein which binds presenilin 1; alzheimer's disease |
| 07/10/2001 | US6258851 Metalloproteinase inhibitors |
| 07/10/2001 | US6258850 3-aryl-2-hydroxypropionic acid derivative (I) |
| 07/10/2001 | US6258846 Enriching breast milk |
| 07/10/2001 | US6258843 4-oxy-3-(aryl)phenyl-arylcarbonyloxy compounds useful as phosphodiesterase inhibitors |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258824 Treatment of hyperproliferative diseases, such as cancers, in mammals. this invention also relates to a pharmaceutical compositions containing such compounds. |